Fundz

GT Medical Technologies raised $37 million in a Series D funding round led by Evidity Health Capital to advance the expansion of GammaTile for brain tumor treatment.

PRIVATEJan 16, 2025

Amount Raised

$37 Million

Round Type

Series D

TempeBiotechnologyHealth CareMedical

Investors

Accelmed PartnersMvm PartnersGilde HealthcareMedtech Venture PartnersEvidity Health Capital

Description

GT Medical Technologies has completed a $37 million Series D financing round, which will accelerate clinical studies and support the commercialization of its GammaTile product. The round was led by Evidity Health Capital and included participation from several other investors.

Quick answer

GT Medical Technologies raised $37 Million in a Series D round, dated January 16, 2025. Investors: Accelmed Partners, Mvm Partners, Gilde Healthcare, Medtech Venture Partners and Evidity Health Capital. GT Medical Technologies is based in Tempe, Arizona, United States.

How much did GT Medical Technologies raise?
GT Medical Technologies raised $37 Million in a Series D round on January 16, 2025.
Who invested in GT Medical Technologies?
Accelmed Partners, Mvm Partners, Gilde Healthcare, Medtech Venture Partners and Evidity Health Capital are named as investors in this round.
What does GT Medical Technologies do?
GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors.
Where is GT Medical Technologies based and how big is it?
GT Medical Technologies is based in Tempe, Arizona, United States. Fundz records about 120 employees.
Who are the decision-makers at GT Medical Technologies?
Fundz holds 1 contact at GT Medical Technologies. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as GT Medical Technologies that raised within 45 days of this round, from Fundz verified event records.

  • QT Imaging Holdings raised $10M (Debt Financing) on February 27, 2025.
  • Neochord raised $493K (Seed) on February 27, 2025.
  • MOC Cancer Care & Research Centre raised $18M (Funding Round) on February 26, 2025.
  • EvidenceHunt raised $1.3M (Funding Round) on February 26, 2025.
  • QT Sense raised $6.3M (Angel) on February 25, 2025.
  • Monument Therapeutics raised $1.1M (Seed) on February 25, 2025.

Who to call at GT Medical Technologies, and when

A new round usually means GT Medical Technologies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GT Medical Technologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GT Medical Technologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GT Medical Technologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GT Medical Technologies

Location

1809 S HOLBROOK LANE, SUITE 107

Tempe, Arizona, United States

About

GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 1000+ patients with brain tumors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GT Medical Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for GT Medical Technologies's next move

See what Strategic adds

GT Medical Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.